Kewaunee Scientific (NASDAQ:KEQU) announced its quarterly earnings data on Tuesday. The technology company reported $0.62 EPS for the quarter, Bloomberg Earnings reports. Kewaunee Scientific had a return on equity of 10.77% and a net margin of 3.28%. The business had revenue of $41.47 million during the quarter.
Kewaunee Scientific (NASDAQ:KEQU) opened at $28.50 on Thursday. Kewaunee Scientific has a twelve month low of $20.95 and a twelve month high of $31.20. The company has a current ratio of 2.58, a quick ratio of 1.79 and a debt-to-equity ratio of 0.05. The firm has a market capitalization of $75.17, a price-to-earnings ratio of 16.59 and a beta of 0.08.
The business also recently declared a quarterly dividend, which will be paid on Monday, December 18th. Stockholders of record on Monday, December 4th will be issued a dividend of $0.17 per share. The ex-dividend date is Friday, December 1st. This represents a $0.68 annualized dividend and a dividend yield of 2.39%. Kewaunee Scientific’s payout ratio is presently 40.72%.
In related news, Director Donald F. Shaw purchased 1,000 shares of Kewaunee Scientific stock in a transaction dated Monday, September 11th. The stock was purchased at an average cost of $27.75 per share, for a total transaction of $27,750.00. Following the completion of the acquisition, the director now directly owns 21,000 shares of the company’s stock, valued at $582,750. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. 20.20% of the stock is owned by company insiders.
A hedge fund recently raised its stake in Kewaunee Scientific stock. Vanguard Group Inc. grew its stake in shares of Kewaunee Scientific Corporation (NASDAQ:KEQU) by 38.0% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 59,560 shares of the technology company’s stock after acquiring an additional 16,400 shares during the quarter. Vanguard Group Inc. owned about 2.20% of Kewaunee Scientific worth $1,486,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 36.68% of the company’s stock.
WARNING: “Kewaunee Scientific (KEQU) Issues Quarterly Earnings Results” was originally published by Stock Observer and is the property of of Stock Observer. If you are reading this story on another domain, it was copied illegally and republished in violation of US & international trademark & copyright laws. The legal version of this story can be read at https://www.thestockobserver.com/2017/12/07/kewaunee-scientific-kequ-issues-quarterly-earnings-results.html.
About Kewaunee Scientific
Kewaunee Scientific Corporation is engaged in the design, manufacture and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel, wood and laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services.
Receive News & Ratings for Kewaunee Scientific Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific Corporation and related companies with MarketBeat.com's FREE daily email newsletter.